Lacri Stulln ud eye drops, 120x0.5 ml

Upute za korištenje Lacri Stulln ud eye drops, 120x0.5 ml

Important notes (compulsory information):

Lacri Stulln UD 20 mg povidone / 1 ml, eye drops. Active substance: Povidon. Areas of application: For symptomatic therapy of the dry eye.

For risks and side effects, read the package leaflet and ask your doctor or pharmacist.


LEAFLET: INFORMATION FOR THE USER

Lacri-Stulln UD 20 mg povidone / 1 ml, eye drops for applying children and adults
Active substance: Povidone (viscosity: a 1% aqueous solution: 1.24 - 1.26 mm2 / s)

Read the entire leaflet carefully because it contains important information for you. This medicine is available without prescription. However, in order to achieve the best possible treatment success, Lacri-Stulln UD must be used properly.

• Lift the package leaflet. You might want to read it again.
• Ask your pharmacist if you need more information or advice.
• If your symptoms get worse or no improvement occurs, you must definitely visit a doctor.
• If one of the listed side effects you significantly affect it or notice side effects that are not specified in this information information, please inform your doctor or pharmacist.

This leaflet contains:

1. What is Lacri-Stulln UD and what is it used for?
2. What do you need to consider before using Lacri-Stulln UD?
3. How is Lacri-Stulln UD to apply?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. How to keep Lacri-Stulln UD?
6. ADDITIONAL INFORMATION

1. What is Lacri-Stulln UD and what is it used for?

Lacri-Stulln UD is an artificial tear fluid. Application: For symptomatic therapy of the dry eye.

2. What do you need to consider before using Lacri-Stulln UD?

Lacri-Stulln UD must not be used if they are hypersensitive (allergic) against the active substance or any of the other ingredients of Lacri-Stulln UD. Take special care with Lacri-Stulln UD, if you wear contact lenses. You must remove these before the application and may be used at the earliest 15 minutes after the application. After applying Lacri-Stulln UD, it can come to fogging at short notice. Patients should not participate in road traffic, do not work without secure hold or operate machines before this impairment has subsided.

When using Lacri-Stulln UD with other medicines:
Please inform your doctor or pharmacist if you have applied other medicines or recently applied, even if it is non-prescription medicines.

Pregnancy and breast feeding period:
Ask your doctor or pharmacist for advice before applying all medicines. Take special care with Lacri-Stulln UD is required in pregnancy and lactation. There are no data for placental days and transition to the breast milk. Damaged effects are not expected.

Driveion and use of machines:
For a short time after administration of PVP solutions, they may not carry a vehicle and, do not use tools or machines, because higher viscosity is the risk of fogging.

3. How is Lacri-Stulln UD to apply?

Always use Lacri-Stulln UD exactly as directed in this leaflet. Please ask your doctor or pharmacist if you are not sure. Unless otherwise prescribed by the doctor, the usual dose is: 1 - 2 drops up to 5 times a day or more frequently in the conjunctivable bag. The local safety of Lacri-Stulln UD was only about one 14-day application examined. For use on the eye.

Duration of application:
Do not use Lacri-Stulln UD without a medical advice no longer than 14 Days on. Please talk to your doctor or pharmacist when SiE have the impression that the effect of Lacri-Stulln UD is too strong or too weak.

If you forget the application of Lacri-Stulln UD:
Do not apply twice the dose if you forget the previous application.

If you have further questions about the application of the medicine, ask your doctor or pharmacist.

4. Which side effects are possible?

Like all medicines, Lacri-Stulln UD may have side effects, but they do not have to occur each other. The assessment of side effects is based on the following frequency information:

The frequency information on side effects is based on the following categories:
Very often:	more than 1 treated from 10
Frequently:	1 to 10 treated from 100
Occasionally:	1 to 10 treated from 1 000
Rarely:	1 to 10 treated from 10 000
Very rare:	less than 1 treated from 10 000
Not known:	Frequency on the basis of the available data does not estimate.

Possible side effects:
Very rarely hypersensitivity reactions occur. At higher viscosity, there is a short time after administration of PVP solutions.

Other possible side effects:
In very rare cases, patients developed with pronounced corneal defects under therapy with phosphate-containing eye drop turbidity of the cornea by the formation of calcium phosphate.

Please inform your doctor or pharmacist if one of the listed side effects will significantly affect it or notice side effects that are not specified in this document formation.

Message of suspicion on side effects:
If you notice side effects, contact your doctor or pharmacist. This also applies to side effects that are not specified in this leaflet. You can also effectively effect the Federal Institute for Medicines and Medical Devices, Dept. Pharmacovigilance, Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, website: www.bfarm.de. By reporting side effects, you can help to provide more information about the security of this medicine.

5. How to keep Lacri-Stulln UD?

Store drug out of reach of children. They may be the medicine after the on the label and container. Do not use until specified expiration date. The expiry date refers to the last day of the month. After opening the sealing edge bag, the unopened one-dose containers 3 Months durable. Open seal edge bag in the original pack (Folding carton) store to protect the content from light.

Storage conditions:
Do not store over 25 ° C

Note on durability after breaking or preparation:
The one-dose containers are intended for single use.

6. Further information:

What Lacri-Stulln UD contains:
The active ingredient is: 1 single dose container contains 0.5 ml with 10 mg povidone. The other ingredients are: sodium date, sodium monohydrogen phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate, sodium chloride, water.

Like Lacri-Stulln UD looks like and content of the pack:
One-dose containers of polyethylene comprising: 30 x 0.5 ml, 60 x 0.5 ml, 120 x 0.5 ml

Pharmaceutic entrepreneur
Pharma Stulln GmbH
Werkstrasse 3
92551 stulln
E-Mail: [email protected]
Internet: www.pharmastrulln.de

This information information was last revised in May 2015.

Source: Information of the leaflet
Status: 05/2016